Explore the role of spatial biology in unraveling the heterogeneity of pancreatic ductal adenocarcinoma-from mouse tissue to human samples
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a complex tumor microenvironment (TME), that plays a pivotal role in disease progression and resistance to therapy. Investigating the spatial distribution and interaction of TME cells with the tumor is the basis for understanding the mechanisms underlying disease progression and represents a current challenge in PDAC research.
In this webinar you'll learn
How Imaging Mass Cytometry™ (IMC™) technology can be used to assess the abundance, distribution and phenotypes of cells involved in PDAC progression in different preclinical transplanted and genetic murine disease models
How IMC was used to analyze 8 human PDAC tissues, to provide information on the cellular constituents of PDACs and related molecular pathways, specifically capable of characterizing 19 different cancer-associated fibroblast clusters
How integrating mouse and human model analyses provide a comprehensive understanding of tumor-immune-stroma interactions, bridging the gap between preclinical and clinical research to inform future therapeutic strategies
Chat and interact with us!
When you watch the recording, you will still be able to reach out to us with questions through the chat and participate in the experience as if it were live!